Active ingredientLumiracoxibCat. No. P-L109-001CAS 220991-20-8Family · Pharmaceutical analytical standards
Lumiracoxib
A selective COX-2 inhibitor non-steroidal anti-inflammatory drug, patented in 1997 and first approved in 2003; from 2007 it was withdrawn from the market in many countries, and it was never approved in the United States. This family brings together the active ingredient, metabolites and nitrosamines.
Did you know?It is the only acidic coxib: structurally it is an analogue of diclofenac, and it binds COX-2 at a different site from the other selective inhibitors.
Go to the active ingredient →Active ingredientLumiracoxibCat. No. P-L109-001CAS 220991-20-8
MetaboliteLumiracoxib Metabolite 1Cat. No. P-L109-002
MetaboliteLumiracoxib Metabolite 2Cat. No. P-L109-003
NitrosamineN-Nitroso LumiracoxibCat. No. P-L109-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.